Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jan 4:9:1032219.
doi: 10.3389/fmed.2022.1032219. eCollection 2022.

Editorial: Management of osteoporosis in patients with chronic kidney disease

Mohamed Abdalbary  1 , Mahmoud Sobh  1 , Eman Nagy  1 , Sherouk Elnagar  1 , Nehal Elshabrawy  1 , Rasha Shemies  1 , Mostafa Abdelsalam  1 , Kamyar Asadipooya  2 , Alaa Sabry  1 , Amr El-Husseini  3
Affiliations
Editorial

Editorial: Management of osteoporosis in patients with chronic kidney disease

Mohamed Abdalbary et al. Front Med (Lausanne). .
No abstract available

Keywords: CKD-MBD; FGF-23; machine learning; osteoporosis; osteoprotegerin; trabecular bone score; transplantation; vitamin D.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Management of osteoporosis in patients with chronic kidney disease

References

    1. Van Der Zee S, Baber U, Elmariah S, Winston J, Fuster V. Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol. (2009) 6:580–9. 10.1038/nrcardio.2009.121 - DOI - PubMed
    1. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, et al. . Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. (1997) 89:309–19. 10.1016/S0092-8674(00)80209-3 - DOI - PubMed
    1. Scialla JJ, Kao WHL, Crainiceanu C, Sozio SM, Oberai PC, Shafi T, et al. . Biomarkers of vascular calcification and mortality in patients with ESRD. Clin J Am Soc Nephrol. (2014) 9:745–55. 10.2215/CJN.05450513 - DOI - PMC - PubMed
    1. Marques GL, Hayashi S, Bjällmark A, Larsson M, Riella M, Olandoski M, et al. . Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3-5. Sci Rep. (2021) 11:2473. 10.1038/s41598-021-82072-z - DOI - PMC - PubMed
    1. Nitta K, Akiba T, Uchida K, Otsubo S, Takei T, Yumura W, et al. . Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients. Nephrol Dial Transplant. (2004) 19:1886–9. 10.1093/ndt/gfh263 - DOI - PubMed

Publication types

LinkOut - more resources